AstraZeneca: a stock for all seasons
Robert Stephens, CFA, discusses why pharmaceuticals giant AstraZeneca could produce capital growth in 2020 and beyond.
4 years ago
Equities
Condor Gold: much closer to production
Stronger gold and a revised plan means this junior miner has cash flow in its sights much earlier than investors…
4 years ago
Why these 3 stocks could offer defensive appeal as the FTSE 100 falls
Robert Stephens, CFA, discusses the prospects for three stocks that could offer defensive characteristics in the wake of the coronavirus outbreak.
4 years ago
Tekmar Group – a long-term winner in the making
Tekmar Group is a long-term winner in the making and its shares at just 168p offer strong growth potential, argues…
4 years ago
Small cap round up featuring: Sureserve, Inland Homes, Medica and more…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the…
4 years ago
Circassia Pharmaceuticals – these shares could double over the next year
Circassia shares have been in the doldrums for some time now, but brokers are expecting a turnaround in fortunes, writes…
4 years ago
Why Admiral is my favourite dividend growth stock
John Kingham doesn’t ‘fall in love’ with individual companies. But if he had to pick a favourite, Admiral would be…
4 years ago
BAE is fighting fit after its double-whammy of acquisitions
Robert Stephens, CFA, discusses why BAE Systems could offer investment potential after its latest acquisitions.
4 years ago
Petra Diamonds – heightened interest could well lift its shares
Down-and-out miner Petra Diamonds could see its shares sparkle once more, writes Mark Watson-Mitchell.
4 years ago
Small cap round up: featuring Rank, Chemring, Finsbury Food and more…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the…
4 years ago